why choose us

Clinical Trials Search

Showing 14,500 of 132,656 result(s)
Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults

Status: Completed

Condition: Interstitial Lung Disease

Interventions: Group 1: 120mg Q4W?group 2: 200mg Q4W

Date: 2023-02-27

Eat My ABCs Project

Status: Completed

Condition: Nutrition, Healthy

Interventions:

The "Eat My ABCs" curriculum incorporates senses into learning (hear, see, smell, taste) and includes two sessions;week: 1) healthy

Date: 2023-02-27

Understanding the Effects of Transauricular Vagus Nerve Stimulationon on Neural Networks and Autonomic Nervous System

Status: Completed

Condition: Healthy Volunteers

Interventions: Transauricular vagus nerve stimulation (taVNS) is a simple technique in which small surface electrodes are placed over the skin of the ear that are th

Date: 2023-02-27

Rural Area Pharmacist Intervention for Diabetes

Status: COMPLETED

Condition: Type 2 Diabetes

Interventions: The pharmacist will perform an initial comprehensive review of the medication regimen, make any adjustments, document those in the patient's elec

Date: 2023-02-27

Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients

Status: COMPLETED

Condition: Atherosclerotic Cardiovascular Disease

Interventions: Atozet 10;40 mg or 10;80 mg Dosage Formulation: Tablet Dosing Instructions: oral.
Take 1 tablet daily

Date: 2023-02-27

Esophageal pH-MII Duration: 12 or 24 Hours?

Status: COMPLETED

Condition: Gastro Esophageal Reflux

Interventions: A pH-MII probe is inserted nasally into the esophagus, and the position verified by chest radiograph.
pH-MII data are evaluated using manufacture

Date: 2023-02-27

Evaluation of Butyrate and Palmitoylethanolamide in IBS Patients (B;P3_1)

Status: COMPLETED

Condition: Irritable Bowel Syndrome With Diarrhea

Interventions: randomized in a 1:1 ratio to treatment Butir+Pea or treatment with Placebo for six weeks.
After the first treatment period, there is a 14-day was

Date: 2023-02-27

Modified HFNC Therapy for ARF Patients Undergoing Flexible Bronchoscopy

Status: COMPLETED

Condition: Acute Hypoxemic Respiratory Failure

Interventions: In the modified HFNC group, high-flow devices (AIRVOTM 2; Fisher & Paykel Healthcare, Auckland, New Zealand) were utilized for respiratory support

Date: 2023-02-27